RIGENASIDE
LIVE

Serial Number

79373811

Owner

FARMACEUTICI DAMOR S.P.A.

Attorney

Ben Natter

Filing Date

Apr 5, 2023

Add to watchlist:

No watchlists yet
View on USPTO

RIGENASIDE Trademark

Serial Number: 79373811 • Registration: 7602060

RIGENASIDE is a trademark filed by FARMACEUTICI DAMOR S.P.A. on April 5, 2023. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

FARMACEUTICI DAMOR S.P.A. (6 trademarks)

NAPOLI , IT

Entity Type: 03

Trademark Details

Filing Date

April 5, 2023

Registration Date

December 17, 2024

Published for Opposition

October 15, 2024

Goods & Services

Cosmetic creams; cosmetic barrier creams; skin care preparations, other than for medical purposes; non-medicated creams for stretch marks and cellulite blemishes; cosmetic firming and slimming creams; anti-aging creams; anti-wrinkle creams; creams for skin spots, other than for medical purposes; non-medicated face and body exfoliant creams and moisturizers; massage creams and oils; beauty masks; non-medicated face and body soaps and gels; non-medicated skin care creams; soaps and intimate hygiene preparations, other than for medical purposes; cosmetic preparations for tanning the skin and sunscreen preparations; nail care preparations, other than for medical purposes; nail varnish; body cleaning preparations; deodorants and antiperspirants; make-up preparations and make-up removers; foundation and face make-up; non-medicated hair and bath preparations and treatments; hair removal and shaving preparations; non-medicated sanitary preparations being toiletries; perfumery; fragrances; essential oils and bath oils for use in aroma therapy; non-medicated oral hygiene preparations

Syringes for medical purposes; disposable syringes; syringes for injections; vaginal syringes; hypodermic syringes; applicators for pharmaceutical preparations in the nature of syringes; apparatus for administering intravenous solutions in the nature of syringes; intravenous administration instruments for medical purposes in the nature of syringes; devices for injecting pharmaceuticals in the nature of syringes; apparatus for administering pharmaceuticals in the nature of syringes; medical apparatus and instruments for use in the removal of blemishes in subjects with signs of skin aging; therapeutic facial masks; apparatus, devices and instruments used in aesthetic medicine and dermatology treatments in the nature of medical devices to remove blemishes in subjects with signs of skin aging; apparatus, devices and instruments used in curative cosmetics in the nature of facial toning machines for cosmetic use; medical equipment, devices and instruments used in cosmetics in the nature of medical devices for nonsurgical cosmetic treatments; injectors for medical purposes; surgical implants comprised of artificial material; esthetic massage apparatus; apparatus for acne treatment

Pharmaceutical preparations for the treatment of dermatological diseases and disorders; natural remedies for the treatment of dermatological diseases and disorders in the nature of wheat-based preparations; pharmaceutical products for gynecological use, namely, therapeutic topical creams for the treatment of gynecological diseases and disorders; medical preparations for dermatological use; pharmaceutical creams, namely, medicated lip creams, creams for dermatological use; medicinal creams for skin care; protective creams for dermatological use; topical analgesic creams; medicated creams and medical preparations for treatment of scars, skin blemishes, dermatitis and psoriasis; medicinal creams and medicated preparations for intimate hygiene; dressings, medical; sterilized dressing; disinfectants and antiseptics; bandages and plasters for skin wounds; cotton for medical purposes; sanitary preparations for medical use; medicinal mud; bath preparations for medical purposes; nutritional supplements and dietary supplements for human use; pre-filled syringes for medical purposes, namely, syringes sold filled with pharmaceutical preparations for the treatment of dermatological diseases and conditions; gauze for dressings

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 13, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 23, 2025 FICS
FINAL DISPOSITION PROCESSED
May 23, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 17, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 28, 2024 OPNX
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 17, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 17, 2024 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 11, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 11, 2024 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 15, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 15, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 25, 2024 NONP
NOTIFICATION PROCESSED BY IB
Jul 28, 2024 GPNX
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 26, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 26, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 26, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 26, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 26, 2024 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 24, 2024 ZZZX
NOTIFICATION PROCESSED BY IB
Jul 1, 2024 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 14, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 13, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 12, 2024 OP2R
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jun 11, 2024 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
May 23, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
May 23, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 23, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
May 23, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 23, 2024 CNEA
CORRESPONDENCE E-MAILED
May 23, 2024 GRML
TEAS/EMAIL CORRESPONDENCE ENTERED
May 23, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 23, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 23, 2024 TROA
REFUSAL PROCESSED BY IB
Feb 14, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 25, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jan 25, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 10, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jan 9, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 2, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 20, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 16, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 13, 2023 REPR